Display options
Share it on

Environ Health Perspect. 1978 Jun;24:117-27. doi: 10.1289/ehp.7824117.

Factors influencing reproduction and genetic toxic effects on male gonads.

Environmental health perspectives

I P Lee, R L Dixon

PMID: 17539139 PMCID: PMC1637207 DOI: 10.1289/ehp.7824117

Abstract

The objective of toxicological study of a target organ, such as the testis, is to elucidate the qualitative and quantitative toxic effects of a chemical on that organ. The ultimate objective is to assess the toxic effects of a chemical in laboratory animals and extrapolate the pertinent experimental data to man. To accomplish these objectives, one must consider the main factors which may influence and modulate the toxic effects of chemicals in the organ. In the male gonads, such modifying factors are the pharmacokinetic parameters governing the absorption, distribution, activation and detoxification of indirect carcinogens, covalent bindings to macromolecules, and DNA damage as well as DNA repair of damaged germ cells. All of these factors have been presently studied in our laboratory and are discussed in this paper with the exception of covalent bindings to macromolecules.The pharmacokinetic studies demonstrated that the functional blood-testis barrier (BTB) closely resembles the blood-brain barrier in transport characteristics: the permeability of nonelectrolytes and the acidic drugs with pK(a) values depend upon their molecular size and their partition coefficients, respectively. Thus, the functional BTB, restricts the permeability of many foreign compounds to male germ cells. Studies of mixed function oxidases and cytochrome P-450 system in male gonads demonstrated that the presence of AHH, EH, and GSH-ST implicate activation and detoxification of polycyclic hydrocarbons. Thus, active electrophiles may exert significant toxic effects locally within both interstitial and germ cell compartments. The presence of an efficient DNA repair system in premeiotic spermatogenic cells (and not in spermiogenic cells) can further modify both toxic and mutagenic events in the subsequent differentiation of germ cells to mature spermatozoa.

References

  1. J Pharmacol Exp Ther. 1960 Sep;130:20-5 - PubMed
  2. J Pharm Sci. 1969 Sep;58(9):1106-9 - PubMed
  3. J Pharmacol Exp Ther. 1958 May;123(1):81-8 - PubMed
  4. J Pharmacol Exp Ther. 1967 Jul;157(1):245-53 - PubMed
  5. J Physiol. 1969 Jan;200(1):73-85 - PubMed
  6. Environ Health Perspect. 1973 Dec;6:59-63 - PubMed
  7. Science. 1975 Dec 5;190(4218):991-2 - PubMed
  8. Toxicol Appl Pharmacol. 1972 Sep;23(1):20-41 - PubMed
  9. Life Sci. 1974 Jun 1;14(11):2121-30 - PubMed
  10. J Pharmacol Exp Ther. 1973 Dec;187(3):641-52 - PubMed
  11. J Pharmacol Exp Ther. 1973 Sep;186(3):600-8 - PubMed
  12. Cancer Res. 1973 Aug;33(8):1849-53 - PubMed
  13. Toxicol Appl Pharmacol. 1972 Oct;23(2):288-325 - PubMed
  14. J Pharmacol Exp Ther. 1972 May;181(2):219-26 - PubMed
  15. J Mol Biol. 1972 May 28;66(3):319-37 - PubMed
  16. J Pharmacol Exp Ther. 1972 Apr;181(1):192-9 - PubMed
  17. Biophys J. 1971 Jun;11(6):502-20 - PubMed
  18. J Pharmacol Exp Ther. 1975 Jul;194(1):171-81 - PubMed
  19. Arch Environ Health. 1975 Aug;30(8):396-401 - PubMed
  20. Cancer Res. 1971 Sep;31(9):1307-12 - PubMed
  21. Pflugers Arch. 1970;318(3):225-43 - PubMed
  22. Mutat Res. 1969 Nov-Dec;8(3):639-45 - PubMed
  23. J Reprod Fertil. 1966 Oct;12(2):377-9 - PubMed
  24. Z Anat Entwicklungsgesch. 1967 Aug 23;126(2):138-53 - PubMed
  25. Nature. 1966 Jul 9;211(5045):150-3 - PubMed
  26. J Pharmacol Exp Ther. 1959 Mar;125(3):185-93 - PubMed

Publication Types